RT Book, Section A1 Pastores, Stephen M. A1 Rosenzweig, Michael A. A1 Jakubowski, Ann A. A2 Hall, Jesse B. A2 Schmidt, Gregory A. A2 Kress, John P. SR Print(0) ID 1107723012 T1 Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease T2 Principles of Critical Care, 4e YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071738811 LK accessanesthesiology.mhmedical.com/content.aspx?aid=1107723012 RD 2024/04/20 AB The complications of hematopoietic stem cell transplantation generally relate to the consequences of the cytoreductive therapy, infections, and in the case of allogeneic transplants, immunosuppression and development of graft-versus-host disease.Graft-versus-host disease remains one of the most important complications of allogeneic transplantation.Stem cell transplant recipients may require admission to the intensive care unit for close monitoring for volume and electrolyte issues, vasopressor or renal support, and mechanical ventilation.The approach to the diagnosis and management of infectious disorders in the stem cell transplant recipient is dependent on the underlying disease and prior therapy, timing of the infection relative to the transplant, the type of transplant, the patient's immunologic history and comorbidities.Pulmonary complications develop in up to 60% of allogeneic transplant recipients and are the immediate cause of death in approximately half of the cases.Major noninfectious pulmonary complications in the early transplant period include idiopathic pneumonia syndrome, diffuse alveolar hemorrhage, and periengraftment respiratory distress syndrome; bronchiolitis obliterans syndrome and bronchiolitis obliterans organizing pneumonia occur later.Despite advances in supportive care in the intensive care unit, the mortality rate of allogeneic transplant recipients who develop respiratory failure and multiple organ failure remains extremely high.